Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
CORT
$115.69
+0.83%
CORT
· Corcept Therapeutics Inc
$115.69
+0.95 (+0.83%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$12.60B
Shares
108.10M
Volume · Sep 30
910.47K
Avg daily vol (3M)
1.31M
All earnings calls
Earnings call · FY2019 Q4
Corcept Therapeutics Inc (CORT) Q4 2019 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$87.89M
+31.5% YoY
Diluted EPS
$0.24
+33.3% YoY
Gross margin
98.4%
+0.8 pp YoY
Net income
$29.38M
+33.5% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Feb 20, 2020 · complete as-filed document
SEC periodic report
10-K report
Filed Feb 24, 2020 · complete as-filed document